erythromycin 333 MG Delayed Release Oral Tablet [Ery-Tab]

RxNorm concept 206078, branded drug (sbd). Prescribable name: ERY-TAB 333 MG Delayed Release Oral Tablet.

RxCUI: 206078
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/206078 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

erythromycin 4053

Other names

Ery-Tab 333 MG Delayed Release Oral Tablet

Related concepts

erythromycin 333 MG (SCDC, consists of)
erythromycin 333 MG [Ery-Tab] (SBDC, consists of)
Delayed Release Oral Tablet (DF, has dose form)
Ery-Tab (BN, has ingredient)
erythromycin 333 MG Delayed Release Oral Tablet (SCD, tradename of)

Linked data

NDCs

24338012403
24338012413
50090033900
52959006115
55289052521
55289052530
55289052540
55289052542
55289052563
55289091515
55289091524
58864061530
63629188303
63629188304
66267008815
66267008821
66267008830

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 206078 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/206078 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 206078. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.